WANG Shu-ying, ZHOU Wen-hui, LI Xin-ying, et al. Analysis of Platelet Transfusion in Liver Disease Patient[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2017, 19(4): 328-331.
1 Annabel Blasi.Coagulopathy in liver disease:Lack of an assessment tool [J]. World J Gastroenterol,2015,21(35):10062-10071. 2 太继琼,钱净.肝移植手术血小板应用探讨[J].临床输血与检验,2013,15(1):70. 3 KaufmanRM,DjulbegovicB,Platelet Transfusion:A Clinical Practice Guideline From the AABB [S].2015.5.5. 4 魏世金,黄豪博,范丽萍.血小板输注临床疗效与感染的相关性研究[J].中华医院感染学杂志,2014,24(23):5845-5846. 5 杜春虹,徐佩琦,李红学.血小板输注无效相关因素的研究进展[J].临床输血与检验,2016,18(11):86-90. 6 中华人民共和国卫生部.临床输血技术规范[S].卫医发[2000],184号,200110. 7 刘丽娜,穆士杰,胡兴斌,等.血液病患者预防性血小板输注阈值的比较[J].临床输血与检验,2013,15(3):206-209. 8 Stanworth SJ,Doree C,Estcourt LJ,et al. Compariso n of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation [J].Cochrane Database Syst Rev,2015,18(11):CD010983. 9 Hayashi H,Beppu T,Shirabe K,et al. Management of thrombocytopenia due to liver cirrhosis:a review [J]. World J Gastroenterol,2014,20(10):2595-2605. 10 Cid J,Harm SK,Mark H,et al.Platelet Transfusion–the Art and Science of Compromise [J]. Transfus Med Hemother,2013,40(3):160–171. 11 卢发强,安万新,康炜,等.降低预防性血小板输注剂量对慢性血小板减少症患者出血风险的影响[J].国际输血及血液学杂志,2011,34(4):295. 12 张秋会,张婧,刘丽娜,等. 多次输血后患者血小板输注无效的血小板抗体检测与分析[J].临床输血与检验,2015,17(5):409-412. 13 Stanworth SJ,Dyer C,Choo L,et al .Do all patients with hematologic malignancies and severe tbrombocytopcnia need prophylactic platelet transfusions Background,rationale,and design of a clinical trial(trial of platelet prophylaxis)to assessthe effectiveness of prophylactic platelet transfusions[J].Transfus Med Rev,2010,24(3):163. 14 陈雪,王莉,傅雪梅,等.不同剂量血小板输注效果Meta分析[J].临床输血与检验,2013,15(4):314-317. 15 Assi TB,Haddad A,Baz E. Clinical effectiveness and comparative hospital costs of different platelet dose strategies[J]. Blood Transfus,2014,12(3):307-313.